APA

Fragoulakis V. F., Pallis A. G., Kaitelidou D. K., Maniadakis N. M. & Georgoulias V. G. (2012). Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis. : Lung Cancer (Auckland, N.Z.).

Chicago

Fragoulakis V F, Pallis A G, Kaitelidou D K, Maniadakis N M and Georgoulias V G. 2012. Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis. : Lung Cancer (Auckland, N.Z.).

Harvard

Fragoulakis V. F., Pallis A. G., Kaitelidou D. K., Maniadakis N. M. and Georgoulias V. G. (2012). Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis. : Lung Cancer (Auckland, N.Z.).

MLA

Fragoulakis V F, Pallis A G, Kaitelidou D K, Maniadakis N M and Georgoulias V G. Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis. : Lung Cancer (Auckland, N.Z.). 2012.